부산대학교 도서관

Lyon, Paul C ; Gray, Michael D ; Mannaris, Christophoros ; Folkes, Lisa K ; Stratford, Michael ; Campo, Leticia ; Chung, Daniel Y F ; Scott, Shaun ; Anderson, Mark ; Goldin, Robert ; Carlisle, Robert ; Wu, Feng ; Middleton, Mark R ; Gleeson, Fergus V ; Coussios, Constantin C

In The Lancet Oncology August 2018 19(8):1027-1039

Ng, Quan-Sing ; Goh, Vicky ; Milner, Jessica ; Stratford, Michael R ; Folkes, Lisa K ; Tozer, Gillian M ; Saunders, Michele I ; Hoskin, Peter J

In Lancet Oncology 2007 8(2):111-118

Bussink, Johan ; Stratford, Michael R.L ; van der Kogel, Albert J ; Folkes, Lisa K ; Kaanders, Johannes H.A.M

In Radiotherapy and Oncology 2002 63(3):285-291

Folkes, Lisa K; Greco, Olga; Dachs, Gabi U; Stratford, Michael R.L; Wardman, Peter

In Biochemical Pharmacology 2002 63(2):265-272

Kestell, Philip ; Zhao, Liangli ; Jameson, Michael B ; Stratford, Michael R.L ; Folkes, Lisa K ; Baguley, Bruce C

In Clinica Chimica Acta 2001 314(1):159-166

Folkes, Lisa K ; Dennis, Madeleine F ; Stratford, Michael R.L ; Candeias, Luis P ; Wardman, Peter

In Biochemical Pharmacology 1999 57(4):375-382

Greco, Olga; Folkes, Lisa K; Wardman, Peter; Tozer, Gillian M; Dachs, Gabi U

Cancer Gene Therapy. Nov2000, Vol. 7 Issue 11, p1414. 7p.

Rossiter, Sharon ; Folkes, Lisa K; Wardman, Peter

In Bioorganic & Medicinal Chemistry Letters 2002 12(18):2523-2526

Woodcock, Victoria K; Clive, Sally; Wilson, Richard H; Coyle, Vicky M; Stratford, Michael R L; Folkes, Lisa K; Eastell, Richard; Barton, Claire; Jones, Paul; Kazmi-Stokes, Shamim; Turner, Helen; Halford, Sarah; Harris, Adrian L; Middleton, Mark R

British Journal of Cancer. 3/20/2018, Vol. 118 Issue 6, p770-776. 7p. 1 Diagram, 3 Charts, 2 Graphs.

Wardman, Peter ; Folkes, Lisa K ; Bentzen, Søren M ; Stratford, Michael R.L ; Hoskin, Peter J ; Phillips, H ; Jackson, S

In International Journal of Radiation Oncology, Biology, Physics 1 October 2001 51(2):460-464

Folkes LK; MRC Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, UK.; Bartesaghi S; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo, Uruguay.; Trujillo M; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo, Uruguay.; Wardman P; MRC Oxford Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, UK.; Radi R; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo, Uruguay.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 9423872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2470 (Electronic) Linking ISSN: 10292470 NLM ISO Abbreviation: Free Radic Res Subsets: MEDLINE

Moss, Jennifer; Tinline-Purvis, Helen; Walker, Carol A; Folkes, Lisa K; Stratford, Michael R; Hayles, Jacqueline; Hoe, Kwang-Lae; Kim, Dong-Uk; Park, Han-Oh; Kearsey, Stephen E; Fleck, Oliver; Holmberg, Christian; Nielsen, Olaf; Humphrey, Timothy C

Genes & Development. 24:2705-2716

Eyre TA; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.; Collins GP; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.; Gupta A; Department of Medical Oncology, Christie NHS Hospital Trust, Manchester, United Kingdom.; Coupe N; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.; Sheikh S; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.; Laboratory of Cancer Biology, University of Oxford, Oxford, United Kingdom.; Whittaker J; Celleron Therapeutics Ltd, Oxford, United Kingdom.; Wang LM; Department of Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Campo L; GCP Laboratory, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Soilleux E; Department of Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Tysoe F; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.; Cousins R; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.; La Thangue N; Laboratory of Cancer Biology, University of Oxford, Oxford, United Kingdom.; Celleron Therapeutics Ltd, Oxford, United Kingdom.; Folkes LK; CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Stratford MRL; CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Kerr D; Celleron Therapeutics Ltd, Oxford, United Kingdom.; Nuffield Division of Clinical Laboratory Sciences, Academic Block, University of Oxford, Oxford, United Kingdom.; Middleton MR; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Folkes, Lisa K; Candeias, Luis P

FEBS Letters. 412:305-308

Folkes LK; Formerly of the Gray Cancer Institute and MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.; Bartesaghi S; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo 11800, Uruguay.; Trujillo M; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo 11800, Uruguay.; Wardman P; Formerly of the Gray Cancer Institute and MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.; Radi R; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.; Centro de Investigaciones Biomédicas (CEINBIO), Universidad de la República, Montevideo 11800, Uruguay.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Skwarska A; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.; Calder EDD; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.; Sneddon D; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.; Bolland H; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.; Odyniec ML; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.; Mistry IN; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.; Martin J; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.; Folkes LK; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.; Conway SJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK. Electronic address: stuart.conway@chem.ox.ac.uk.; Hammond EM; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK. Electronic address: ester.hammond@oncology.ox.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

Skwarski M; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Department of Oncology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; McGowan DR; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Radiation Physics and Protection, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Belcher E; Department of Cardiothoracic Surgery, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Di Chiara F; Department of Cardiothoracic Surgery, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Stavroulias D; Department of Cardiothoracic Surgery, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; McCole M; Department of Cellular Pathology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Derham JL; Department of Oncology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Chu KY; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Department of Oncology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Teoh E; Department of Oncology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Chauhan J; Ludwig Institute for Cancer Research Oxford, University of Oxford, Oxford, England, United Kingdom.; O'Reilly D; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Harris BHL; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Macklin PS; Nuffield Department of Medicine, University of Oxford, Oxford, England, United Kingdom.; Bull JA; Wolfson Centre for Mathematical Biology, University of Oxford, Oxford, England, United Kingdom.; Green M; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Rodriguez-Berriguete G; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Prevo R; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Folkes LK; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Campo L; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Ferencz P; Institute of Biomedical Engineering, University of Oxford, Oxford, England, United Kingdom.; Croal PL; Institute of Biomedical Engineering, University of Oxford, Oxford, England, United Kingdom.; Flight H; Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Qi C; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England, United Kingdom.; Holmes J; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England, United Kingdom.; O'Connor JPB; Division of Cancer Sciences, University of Manchester, Manchester, England, United Kingdom.; Gleeson FV; Department of Radiology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; McKenna WG; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Harris AL; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Bulte D; Institute of Biomedical Engineering, University of Oxford, Oxford, England, United Kingdom.; Buffa FM; Department of Oncology, University of Oxford, Oxford, England, United Kingdom.; Macpherson RE; Department of Radiology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.; Higgins GS; Department of Oncology, University of Oxford, Oxford, England, United Kingdom. geoffrey.higgins@oncology.ox.ac.uk.; Department of Oncology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, England, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Rieunier G; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Wu X; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Harris LE; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.; Mills JV; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Nandakumar A; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Colling L; Department of Oncology, Weatherall Institute of Molecular Medicine, Oxford, United Kingdom.; Seraia E; Target Discovery Institute, University of Oxford, Oxford, United Kingdom.; Hatch SB; Target Discovery Institute, University of Oxford, Oxford, United Kingdom.; Ebner DV; Target Discovery Institute, University of Oxford, Oxford, United Kingdom.; Folkes LK; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.; Weyer-Czernilofsky U; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Bogenrieder T; AMAL Therapeutics, Geneva, Switzerland.; Department of Urology, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany.; Ryan AJ; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.; Macaulay VM; Department of Oncology, University of Oxford, Oxford, United Kingdom. valentine.macaulay@nds.ox.ac.uk.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Ashton TM; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Fokas E; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Kunz-Schughart LA; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology, Dresden, P.O. Box 41, 01307, Germany.; Folkes LK; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Anbalagan S; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Huether M; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology, Dresden, P.O. Box 41, 01307, Germany.; Kelly CJ; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Pirovano G; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Buffa FM; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Hammond EM; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Stratford M; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Muschel RJ; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Higgins GS; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; McKenna WG; CRUK/MRC Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Folkes LK; Gray Institute for Radiation, Oncology and Biology, Department of Oncology, University of Oxford, Oxford, UK. Lisa.Folkes@oncology.ox.ac.uk; Bartesaghi S; Trujillo M; Radi R; Wardman P

Publisher: Informa Healthcare Country of Publication: England NLM ID: 9423872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2470 (Electronic) Linking ISSN: 10292470 NLM ISO Abbreviation: Free Radic Res Subsets: MEDLINE